Mild hypothyroidism, known clinically as subclinical hypothyroidism, is a condition where your thyroid gland is underperforming just enough to raise your TSH level above normal, but not enough to drop your actual thyroid hormone levels out of range. Your blood work shows an elevated TSH (typically above 4.5 mIU/L) while your free T4 remains normal. It’s one of the most common thyroid findings, and whether it needs treatment depends on how elevated your TSH is and a handful of other factors.
How It Differs From Full Hypothyroidism
In overt (full) hypothyroidism, both pieces of the puzzle are abnormal: TSH is high and free T4 is low. Your thyroid has clearly fallen behind, and your body is feeling the effects. In mild hypothyroidism, only TSH is elevated. Think of TSH as a signal your brain sends to your thyroid, telling it to work harder. A rising TSH means your brain is shouting louder, but for now the thyroid is still keeping up. Hormone output remains in the normal range, which is why many people with this condition feel perfectly fine.
That said, “subclinical” doesn’t always mean “no symptoms.” Some people do notice fatigue, dry skin, weight changes, or sensitivity to cold. The symptoms tend to be subtler and harder to pin on the thyroid alone, since they overlap with dozens of other causes.
What Causes It
Hashimoto’s thyroiditis, an autoimmune condition in which the immune system gradually attacks the thyroid, accounts for 60% to 80% of cases. A blood test for thyroid peroxidase (TPO) antibodies can confirm whether autoimmune activity is behind the elevated TSH. Other causes include prior thyroid surgery, radioactive iodine treatment, radiation to the neck area, and certain medications like lithium or amiodarone.
Symptoms You Might Notice
Because your thyroid hormone levels are technically still normal, symptoms of mild hypothyroidism are often vague or absent entirely. When they do appear, the most commonly reported include:
- Fatigue that doesn’t improve with rest
- Slight weight gain or difficulty losing weight
- Dry skin or thinning hair
- Feeling cold more easily than usual
- Joint or muscle stiffness
- Low mood or mild depression
- Irregular periods or fertility difficulties in women
Research suggests that even mild thyroid dysfunction is linked to measurable changes in metabolic rate and body composition. Thyroid hormones regulate basal metabolism, heat production, and fat burning, so even a small shortfall can shift the balance. That said, the weight gain associated with subclinical hypothyroidism tends to be modest, and the evidence that treating it leads to significant weight loss is limited.
The TSH Number Matters
Not all mild hypothyroidism carries the same risk. The key dividing line is a TSH of 10 mIU/L. Below that threshold, the condition often resolves on its own. Nearly half of people with a TSH under 10 and normal free T4 will see their levels return to normal within three to six months without any treatment. That’s why most guidelines recommend rechecking your blood work before starting medication.
Above 10 mIU/L, the picture changes. Both the American Thyroid Association and the American Association of Clinical Endocrinologists recommend starting thyroid hormone replacement when TSH exceeds 10. At that level, the risks of leaving it untreated become more concrete, particularly for heart health.
For TSH values between 4.5 and 10, treatment decisions are individualized. Your doctor will weigh factors like whether you have symptoms, whether TPO antibodies are positive (suggesting autoimmune thyroiditis that’s likely to progress), your age, and whether you have cardiovascular risk factors.
Cardiovascular and Cholesterol Effects
The most well-studied risk of untreated mild hypothyroidism involves the heart and blood vessels. Even at the subclinical stage, the condition is associated with higher total cholesterol, higher LDL (“bad”) cholesterol, and lower HDL (“good”) cholesterol. Studies have found that people with subclinical hypothyroidism also show signs of stiffer arteries and early changes in heart function, specifically reduced flexibility of the left ventricle during its filling phase.
When TSH reaches 10 mIU/L or higher, the cardiovascular signal gets stronger. Observational studies have linked this level to an increased risk of coronary artery disease events, heart failure, and fatal stroke. Subclinical hypothyroidism may also contribute to coronary artery calcification, particularly in people who already carry intermediate or high cardiovascular risk. In one analysis, the risk of significant coronary calcium buildup was independently associated with male sex, age over 55, and the presence of subclinical hypothyroidism.
How Likely It Is to Progress
Mild hypothyroidism doesn’t always stay mild. The annual rate of progression to full hypothyroidism is about 2.6% per year if TPO antibodies are absent, and 4.3% per year if they’re present. That means someone who tests positive for both elevated TSH and TPO antibodies has roughly a one-in-four chance of developing overt hypothyroidism within five to six years. This is one reason doctors monitor the condition with periodic blood tests even when they don’t prescribe medication right away.
The risk of progression is especially high in women, people with higher iodine intake, those with TSH already above 10, and those with positive thyroid autoantibodies.
Age Changes the Picture
TSH naturally rises with age. In people over 70, the upper limit of a normal TSH may extend to around 6.0 mIU/L, even after autoimmune thyroid disease has been ruled out. This means a TSH of 5.5 in a 75-year-old may be entirely normal, while the same value in a 30-year-old is more likely to reflect early thyroid dysfunction.
In elderly populations, free T4 doesn’t start to decline meaningfully until TSH rises above 6 to 7 mIU/L, compared to younger adults where the decline begins around 4.5 mIU/L. There’s also little evidence that mildly elevated TSH causes harm in older adults. One study even found decreased frailty in elderly people with raised thyroid autoantibody levels, suggesting that aggressive treatment in this age group may not help and could potentially cause harm from overreplacement.
Pregnancy and Fertility
Pregnancy is the one situation where mild hypothyroidism is treated more aggressively, regardless of the TSH number. The thyroid plays a critical role in fetal brain development, especially during the first trimester before the baby’s own thyroid is functional. Untreated subclinical hypothyroidism in pregnancy has been associated with hypertensive disorders, preterm labor, and impaired cognitive development in infants.
The American Thyroid Association recommends that pregnant women or those undergoing IVF with subclinical hypothyroidism be treated to bring TSH below 2.5 mIU/L. If you’re planning a pregnancy and know your TSH is elevated, this is worth discussing with your doctor before conception rather than after.
What Monitoring Looks Like
If your TSH is mildly elevated but below 10 and you have no symptoms, the typical approach is watchful waiting with repeat blood work in three to six months. If the elevation persists, your doctor will likely test for TPO antibodies to assess whether autoimmune thyroiditis is the cause and to estimate your progression risk. From there, testing every 6 to 12 months is common to track whether your TSH is stable, rising, or returning to normal on its own.
When treatment is started, it involves a daily pill of synthetic thyroid hormone, with the goal of bringing TSH back into the normal range. Follow-up blood work every six to eight weeks after starting or adjusting the dose helps fine-tune the amount. Most people who do need treatment stay on it long-term, though some with transient causes (like medication-induced thyroid suppression) can eventually stop.